28.08.2014 Views

Pregnancy

Pregnancy

Pregnancy

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Liver Diseases in <strong>Pregnancy</strong><br />

................................................................................................................................................................<br />

Wilson Disease:<br />

Wilson disease is an inherited recessive disorder of<br />

copper transport in the golgi apparatus of the hepatocyte.<br />

It leads to the accumulation of copper in the liver,<br />

brain and other organs. It is a disease of the young thus<br />

affecting women of childbearing age. In the absence<br />

of treatment, cirrhosis of the liver, fulminant hepatic<br />

failure and advanced psychiatric and neurologic damage<br />

may occur. While fertility is decreased in patients<br />

with Wilson disease, women have become pregnant<br />

when appropriately diagnosed and treated. Treatment<br />

should be initiated as soon as diagnosis is made during<br />

pregnancy and regardless of the stage of pregnancy.<br />

Treatment should be maintained throughout pregnancy<br />

because its interruption could result in fulminant<br />

liver failure. Dose reduction in the order of 25-50%<br />

of pre-pregnancy maintenance therapy for both chelators<br />

D- penicillamine and trientene is required so that<br />

copper is not depleted from the body and wound healing<br />

is not impaired if C-section is to be performed. 45<br />

In addition, Copper depletion may be associated with<br />

congenital malformations.<br />

While fertility is decreased<br />

in patients with Wilson<br />

disease, women have become<br />

pregnant when appropriately<br />

diagnosed and treated.<br />

Trientene is FDA category C and its dose should be<br />

decreased to less than 500mg /day in pregnancy.<br />

Zinc sulfate (FDA Category C) is probably safe during<br />

pregnancy and breastfeeding. It is usually given at<br />

a dose of 50 mg orally three times daily and does not<br />

require dose adjustment. 49<br />

Primary Biliary Cirrhosis and Primary Sclerosing<br />

Cholangitis:<br />

A few cases of pregnancy have been described in<br />

women with primary biliary cirrhosis (PBC). This is<br />

partly due to the later age at presentation of the disease.<br />

Although reports suggest an increased risk for premature<br />

delivery, still births and liver failure, there are<br />

no good data on the outcome of pregnancy in women<br />

with PBC. When pregnancy occurs, PBC may induce<br />

a new onset pruritus. Diagnosis and management are<br />

similar to the non pregnant state. Upper endoscopy is<br />

recommended 50 in order to screen for esophageal varices.<br />

Nonselective beta blockers and banding ligation<br />

should be given if necessary. Ursodeoxycholic acid or<br />

UDCA (FDA category B) is the treatment of choice<br />

due to its safety as discussed earlier.<br />

Primary sclerosing cholangitis is rarely described in<br />

pregnancy. Abdominal pain and pruritus seem to be<br />

the major symptoms in pregnancy. Diagnosis and<br />

therapy are similar to the non pregnant state.<br />

Budd-Chiari Syndrome:<br />

D-penicillamine is FDA Category D. It has been associated<br />

with teratogenic abnormalities in 5% of infants<br />

(cutis laxa, micrognathia, low-set ears, inguinal<br />

hernias, and joint mobility). 46 The suggested dose in<br />

pregnancy is

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!